Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, 7SL, cytoplasmic 670, pseudogene (RN7SL670P)** is a noncoding RNA pseudogene. It is a truncated genomic copy of the canonical 7SL RNA gene, which encodes the RNA component of the signal recognition particle (SRP), a ribonucleoprotein complex crucial for co-translational protein targeting to the endoplasmic reticulum in eukaryotes[5][3][2]. However, pseudogenes such as RN7SL670P are nonfunctional and do not produce active RNA or protein products. They arise from the reverse transcription and integration of RNA molecules into the genome and can be structurally diverse and truncated compared to the functional 7SL RNA genes[5]. RN7SL670P has no known biological activity, does not function as a receptor, enzyme, or drug target, and is not associated with disease phenotypes or therapeutic intervention[2][5]. **Key notes:** - This is a pseudogene, not an active receptor or therapeutic target, and lacks biological function or disease association. - If searching for actionable molecular targets, the functional "RNA, 7SL, cytoplasmic" (7SL RNA) gene or Signal recognition particle RNA may be relevant[1][3], but this pseudogene is not.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 670, pseudogene (RN7SL670P).